Brief: In8bio Announces Positive Preclinical Data For Gamma-Delta Car Platform And Launches New Cd33 Program At AACR Annual Meeting 2023
17/04/2023 14:03
April 17 (Reuters) - IN8BIO, Inc. INAB.O :
* IN8BIO ANNOUNCES POSITIVE PRECLINICAL DATA FOR GAMMA-DELTA
CAR
PLATFORM AND LAUNCHES NEW CD33 PROGRAM AT AACR ANNUAL MEETING
2023
* IN8BIO, INC. - ANNOUNCES NEW INB-330 PROGRAM TARGETING
CD33 IN
ACUTE MYELOID LEUKEMIA
Source text for Eikon: ID:nGNX5s3PdC
Further company coverage: INAB.O
Recent news on IN8bio
See all newsIN8bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biopharma firm IN8bio's Q2 net loss narrows as expenses decline
IN8bio Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering
IN8bio Q1 net loss narrows as R&D expenses fall